Finding Cures

In 2020, Google DeepMind unveiled AlphaFold 2, a machine-learning algorithm that in 2022 would prove capable of predicting, with near-experimental accuracy, the structure of nearly every known protein. The breakthrough recently earned co-founder and CEO Demis Hassabis and AlphaFold team lead John Jumper a Nobel prize in chemistry. Now there’s a sequel: AlphaFold 3, released in May, predicts how proteins interact with DNA and other molecules. “AlphaFold 2 was a story about proteins,” Jumper says. “AlphaFold 3 is about how proteins talk to everything else.” Many in pharmaceuticals and medicine believe that the new model’s predictions will accelerate research and drive faster drug discovery.

Learn More at Google DeepMind AlphaFold 3